Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Key facts

Sponsor

International Vaccine Institute

Principal Investigator

Sujit K Bhatttacharya, MD

National Institute of Cholera and Enteric Diseases, India

Intervention

Typhoid Vi vaccine(biological)

Enrollment

37673 enrolled

Eligibility

2 years · All sexes

Timeline

2003 – 2008

Study locations (1)

• National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India

Collaborators

National Institute of Cholera and Enteric Diseases, India · Wellcome Trust · University of Western Ontario, Canada · GlaxoSmithKline

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Paratyphoid fever

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT07314281
  Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
  Indus Hospital and Health Network
• RECRUITINGNCT04878549
  Transcriptomic Responses for the Identification of Pathogens
  University of Sheffield

See all trials for Paratyphoid fever →